Recurrent DHA nephropathy in renal allograft-revisiting clinicopathological aspects of a rare entity

Indian J Pathol Microbiol. 2021 Jul-Sep;64(3):504-508. doi: 10.4103/IJPM.IJPM_441_20.

Abstract

Background: Adenine phosphoribosyltransferase (APRT) enzyme deficiency is a rare autosomal recessive disorder of purine metabolism affecting mainly the kidneys. It can present at any age with varying degrees of acute and chronic renal damage. Though xanthine dehydrogenase inhibitors offer effective control over the disease process, delay in diagnosis and treatment often lead to compromised function of native and even graft kidneys.

Methods: We have done a retrospective search of records of renal biopsies reported at our center during the 5-year period from 2014 to 2018 to identify biopsies with 2,8-dihydroxyadenine crystal deposits. The demographic, clinical, and histopathological findings in these cases were studied and reviewed in the light of available literature.

Results: Of 9059 renal biopsies received during the study period, 3 cases had the rare 2,8- dihydroxyadenine (DHA) crystals. All of them were diagnosed for the first time on allograft biopsies.

Conclusion: A high index of clinical suspicion together with the characteristic microscopic appearance of crystals on renal biopsy and urine microscopy can clinch the diagnosis of this rare disease. Hence, improving awareness about this entity among clinicians and pathologists is extremely important.

Keywords: Crystal nephropathy; dihydroxyadenine; recurrent.

Publication types

  • Case Reports

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / chemistry
  • Adenine / urine
  • Adult
  • Allografts
  • Biopsy
  • Crystallization
  • Female
  • Humans
  • Kidney / pathology*
  • Kidney Diseases / pathology*
  • Kidney Diseases / urine*
  • Kidney Transplantation / adverse effects
  • Male
  • Middle Aged
  • Recurrence
  • Retrospective Studies

Substances

  • 2,8-dihydroxyadenine
  • Adenine